Biogen Idec, Inc. (NASDAQ:BIIB)
CAPS Rating:
The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.
RSS Headlines
Fool UK
Recs
Great pipeline - 5 filings over next few years. Nimble size and new leadership will further focus this company and drive continued earnings growth.